Percorrer por autor "Bolstad, Courtney J."
A mostrar 1 - 6 de 6
Resultados por página
Opções de ordenação
- Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors: findings from a survey across 16 countries/regionsPublication . Matsui, Kentaro; Chung, Frances; Bjelajac, Adrijana Koscec; Merikanto, Ilona; Korman, Maria; Mota-Rolim, Sérgio; Cunha, Ana Suely; Bjorvatn, Bjørn; Xue, Pei; Benedict, Christian; Morin, Charles M.; Espie, Colin A.; Landtblom, Anne Marie; Penzel, Thomas; De Gennaro, Luigi; Holzinger, Brigitte; Hrubos-Strøm, Harald; Leger, Damien; Bolstad, Courtney J.; Nadorff, Michael R.; Plazzi, Giuseppe; Reis, Catia; Chan, Ngan Yin; Wing, Yun Kwok; Yordanova, Juliana; Dauvilliers, Yves; Partinen, Markku; Inoue, YuichiBackground: Self-rated health (SRH) is widely recognized as a clinically significant predictor of subsequent mortality risk. Although COVID-19 may impair SRH, this relationship has not been extensively examined. The present study aimed to examine the correlation between habitual sleep duration, changes in sleep duration after infection, and SRH in subjects who have experienced SARS-CoV-2 infection. Methods: Participants from 16 countries participated in the International COVID Sleep Study-II (ICOSS-II) online survey in 2021. A total of 10,794 of these participants were included in the analysis, including 1,509 COVID-19 individuals (who reported that they had tested positive for COVID-19). SRH was evaluated using a 0-100 linear visual analog scale. Habitual sleep durations of < 6 h and > 9 h were defined as short and long habitual sleep duration, respectively. Changes in habitual sleep duration after infection of ≤ -2 h and ≥ 1 h were defined as decreased or increased, respectively. Results: Participants with COVID-19 had lower SRH scores than non-infected participants, and those with more severe COVID-19 had a tendency towards even lower SRH scores. In a multivariate regression analysis of participants who had experienced COVID-19, both decreased and increased habitual sleep duration after infection were significantly associated with lower SRH after controlling for sleep quality (β = −0.056 and −0.058, respectively, both p < 0.05); however, associations between current short or long habitual sleep duration and SRH were negligible. Multinomial logistic regression analysis showed that decreased habitual sleep duration was significantly related to increased fatigue (odds ratio [OR] = 1.824, p < 0.01), shortness of breath (OR = 1.725, p < 0.05), diarrhea/nausea/vomiting (OR = 2.636, p < 0.01), and hallucinations (OR = 5.091, p < 0.05), while increased habitual sleep duration was significantly related to increased fatigue (OR = 1.900, p < 0.01). Conclusions: Changes in habitual sleep duration following SARS-CoV-2 infection were associated with lower SRH. Decreased or increased habitual sleep duration might have a bidirectional relation with post-COVID-19 symptoms. Further research is needed to better understand the mechanisms underlying these relationships for in order to improve SRH in individuals with COVID-19.
- Estimation bias and agreement limits between two common self-report methods of habitual sleep duration in epidemiological surveysPublication . Korman, Maria; Zarina, Daria; Tkachev, Vadim; Merikanto, Ilona; Bjorvatn, Bjørn; Bjelajac, Adrijana Koscec; Penzel, Thomas; Landtblom, Anne Marie; Benedict, Christian; Chan, Ngan Yin; Wing, Yun Kwok; Dauvilliers, Yves; Morin, Charles M.; Matsui, Kentaro; Nadorff, Michael; Bolstad, Courtney J.; Chung, Frances; Mota-Rolim, Sérgio; Gennaro, Luigi De; Plazzi, Giuseppe; Yordanova, Juliana; Holzinger, Brigitte; Partinen, Markku; Reis, CátiaAccurate measurement of habitual sleep duration (HSD) is crucial for understanding the relationship between sleep and health. This study aimed to assess the bias and agreement limits between two commonly used short HSD self-report methods, considering sleep quality (SQ) and social jetlag (SJL) as potential predictors of bias. Data from 10,268 participants in the International COVID Sleep Study-II (ICOSS-II) were used. Method-Self and Method-MCTQ were compared. Method-Self involved a single question about average nightly sleep duration (HSDself), while Method-MCTQ estimated HSD from reported sleep times on workdays (HSDMCTQwork) and free days (HSDMCTQfree). Sleep quality was evaluated using a Likert scale and the Insomnia Severity Index (ISI) to explore its influence on estimation bias. HSDself was on average 42.41 ± 67.42 min lower than HSDMCTQweek, with an agreement range within ± 133 min. The bias and agreement range between methods increased with poorer SQ. HSDMCTQwork showed less bias and better agreement with HSDself compared to HSDMCTQfree. Sleep duration irregularity was − 43.35 ± 78.26 min on average. Subjective sleep quality predicted a significant proportion of variance in HSDself and estimation bias. The two methods showed very poor agreement and a significant systematic bias, both worsening with poorer SQ. Method-MCTQ considered sleep intervals without adjusting for SQ issues such as wakefulness after sleep onset but accounted for sleep irregularity and sleeping in on free days, while Method-Self reflected respondents’ interpretation of their sleep, focusing on their sleep on workdays. Including an SQ-related question in surveys may help bidirectionally adjust the possible bias and enhance the accuracy of sleep-health studies.
- Long COVID as a risk factor for hypersomnolence and fatigue: insights from the 2nd International Covid Sleep Study Collaboration (ICOSS-2)Publication . Sarkanen, Tomi; Merikanto, Ilona; Bjorvatn, Bjorn; Chung, Frances; Holzinger, Brigitte; Morin, Charles M.; Penzel, Thomas; Gennaro, Luigi de; Wing, Yun Kwok; Benedict, Christian; Xue, Pei; Reis, Cátia; Korman, Maria; Landtblom, Anne-Marie; Matsui, Kentaro; Hrubos-Strom, Harald; Mota-Rolim, Sergio; Nadorff, Michael R.; Berezin, Linor; Liu, Yaping; Scarpelli, Serena; Brandão, Luiz E. M.; Cedernaes, Jonathan; Partinen, Eemil; Bolstad, Courtney J.; Plazzi, Giuseppe; Espie, Colin A.; Partinen, Markku; Dauvilliers, YvesBackground: Hypersomnolence, defined as excessive daytime sleepiness (EDS), excessive quantity of sleep (EQS), sleep inertia, and fatigue reduce quality of life. We assessed associations of the COVID-19 pandemic, infection without long-term sequalae (short COVID, SC), and long COVID (LC) on hypersomnolence and fatigue in a large population across different countries. Methods: As part of an online questionnaire (ICOSS-2), we assessed EDS via the Epworth Sleepiness Scale (ESS), fatigue via Fatigue Severity Scale (FSS), and sleep duration at night and per 24 h. We also assessed the associations with EDS, sleep inertia, fatigue and napping by their frequencies, during the pandemic in COVID-negative, SC and LC participants. Results: The final cohort comprised 13,656 participants (69.1 % women, 42.7 ± 16.6 years), with 12.4 % classified SC and 7.5 % LC. ESS scores were higher in LC (9.16, 95 % CI [8.78, 9.53]) compared to SC (7.26, [6.97, 7.55]) and COVID-negative (6.53, [6.43, 6.63]). LC also had higher odds of ESS>10 (OR 1.58, [1.18,2.09]). FSS scores were higher in LC (median 51, IQR 39–59) than SC (34, 25–44) and COVID-negative (35, 25–45), with LC having 2.22 higher odds of severe fatigue. LC cases also reported more EQS (?10/24 h) than COVID-negative. Worsening of EDS, fatigue, sleep inertia, and napping was reported during pandemic to a greater extent in LC. Conclusions: LC was associated with higher levels of hypersomnolence and fatigue than in SC or COVID-negative participants, highlighting the need for interventions and future research focusing on sleep symptoms and their relation to long-term health outcomes.
- Lucid dreaming: not just awareness, but agencyPublication . Ableidinger, Severin; DeGennaro, Luigi; Mota-Rolim, Sergio; Scarpelli, Serena; Bolstad, Courtney J.; Bjorvatn, Bjørn; Espie, Colin A.; Dauvilliers, Yves; Korman, Maria; Landtblom, Anne Marie; Plazzi, Giuseppe; Matsui, Kentaro; Yordanova, Juliana; Bjelajac, Adrijana Koscec; Reis, Cátia; Chung, Frances; Merikanto, Ilona; Wing, Yun K.; Partinen, Markku; Macêdo, Tainá; Nadorff, Michael R.; Holzinger, BrigitteDuring lucid dreaming (LD), dreamers are aware that they are dreaming and may be able to influence the oneiric content. There has been recent debate about the relative importance of the ability to influence the dream and having agency over the pure awareness of dreaming. To underline this, we examined the associations of lucid dreams without agency (LD?Ag) and lucid dreams with agency (LD + Ag) to sleep and mental health problems and long COVID during the pandemic. We collected data in 16 countries on four continents from May to December 2021 on 10,715 subjects. Logistic regression was performed to predict LD?Ag and LD + Ag, with a sample of 8133 participants. We found that 30% of the participants frequently knew they were dreaming during the pandemic. About half of those (17%) reported that they could influence their dreams. Female gender and anxiety symptoms were negatively associated with LD + Ag. Dream recall, nightmares, insomnia, dream enactment behaviour (DEB), sleep vocalisation, short and long COVID and PTSD were positively associated with LD + Ag. Old age, dream recall, nightmares and anxiety symptoms were positively associated with LD?Ag, while short sleep length, being an evening type, and short COVID were negatively associated with LD?Ag. The different associations for LD?Ag and LD + Ag suggest that they may be distinct sleep states. This is also the first study to show that both COVID-19 and long COVID are associated with LD.
- Persistent short nighttime sleep duration is associated with a greater post-COVID risk in fully mRNA-vaccinated individualsPublication . Xue, Pei; Merikanto, Ilona; Chung, Frances; Morin, Charles M.; Espie, Colin; Bjorvatn, Bjørn; Cedernaes, Jonathan; Landtblom, Anne Marie; Penzel, Thomas; Gennaro, Luigi de; Holzinger, Brigitte; Matsui, Kentaro; Hrubos-Strøm, Harald; Korman, Maria; Leger, Damien; Mota-Rolim, Sérgio; Bolstad, Courtney J.; Nadorff, Michael; Plazzi, Giuseppe; Reis, Cátia; Chan, Rachel Ngan Yin; Wing, Yun Kwok; Yordanova, Juliana; Bjelajac, Adrijana Koscec; Inoue, Yuichi; Partinen, Markku; Dauvilliers, Yves; Benedict, ChristianShort nighttime sleep duration impairs the immune response to virus vaccination, and long nighttime sleep duration is associated with poor health status. Thus, we hypothesized that short (<6 h) and long (>9 h) nighttime sleepers have a higher post-COVID risk than normal nighttime sleepers, despite two doses of mRNA vaccine (which has previously been linked to lower odds of long-lasting COVID-19 symptoms). Post-COVID was defined as experiencing at least one core COVID-19 symptom for at least three months (e.g., shortness of breath). Multivariate logistic regression adjusting for age, sex, BMI, and other factors showed in 9717 respondents (age span 18–99) that two mRNA vaccinations lowered the risk of suffering from post-COVID by about 21% (p < 0.001). When restricting the analysis to double-vaccinated respondents (n = 5918), short and long sleepers exhibited a greater post-COVID risk than normal sleepers (adjusted OR [95%-CI], 1.56 [1.29, 1.88] and 1.87 [1.32, 2.66], respectively). Among respondents with persistent sleep duration patterns during the pandemic compared to before the pandemic, short but not long sleep duration was significantly associated with the post-COVID risk (adjusted OR [95%-CI], 1.59 [1.24, 2.03] and 1.18 [0.70, 1.97], respectively). No significant association between sleep duration and post-COVID symptoms was observed in those reporting positive SARS-CoV-2 test results (n = 538). Our findings suggest that two mRNA vaccinations against SARS-CoV-2 are associated with a lower post-COVID risk. However, this protection may be less pronounced among those sleeping less than 6 h per night. Our findings warrant replication in cohorts with individuals with confirmed SARS-CoV-2 infection.
- Prevalence rates of frequent dream recall and nightmares by age, gender and sleep duration in 16 countriesPublication . Bolstad, Courtney J.; Bjorvatn, Bjørn; Chan, Ngan Yin; Chung, Frances; Dauvilliers, Yves; De Gennaro, Luigi; Espie, Colin A.; Holzinger, Brigitte; Inoue, Yuichi; Korman, Maria; Koscec Bjelajac, Adrijana; Landtblom, Anne Marie; Macêdo, Tainá; Matsui, Kentaro; Merikanto, Ilona; Morin, Charles M.; Mota-Rolim, Sérgio; Penzel, Thomas; Plazzi, Giuseppe; Reis, Cátia; Scarpelli, Serena; Wing, Yun Kwok; Nadorff, Michael R.The present study aimed to describe the prevalence rates of frequent (i.e., at least weekly) dream recall and nightmares with consideration for differences in age, gender and sleep duration in 16 countries using equivalent assessment methods. The study sample included 15,854 participants (69.9% women) aged 18–99 years (M = 42.39, SD = 16.43) collected by the International COVID-19 Sleep Study collaboration, which used a unified online survey to collect data from May to November 2021 across 16 countries. Participants provided demographic information as well as self-reported estimates of their dream recall and nightmare frequency and sleep duration in 2021 and retrospectively for 2019. Frequent dream recall occurred in 54.0% of participants in 2021 and 51.1% in 2019. Frequent nightmares were reported by 11.0% of participants in 2021 and 6.9% in 2019. Ad hoc regression models found dream recall and sleep duration to have a linear relation, whereas nightmare frequency demonstrated a quadratic relation to sleep duration. Frequent dream recall and nightmare prevalence rates are reported for each of the 16 study countries by age, gender and sleep duration. This is the first multi-continent study to estimate frequent dream recall and nightmare prevalence, which both provides updated prevalence rates during the COVID-19 pandemic as well as extends existing knowledge to previously never studied countries.